Altimmune to Present at the 2021 Jefferies Virtual Healthcare Conference

Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the management team will present during a fireside chat at the 2021 Jefferies Virtual Healthcare Conference, being held June 1 - 4, 2021.

Details on the Jefferies fireside chat presentation are as follows:

	Title:		2021 Jefferies Virtual Healthcare Conference

	Presenters:		Vipin Garg, Ph.D., Chief Executive Officer
			Scot Roberts, Ph.D., Chief Scientific Officer
			Scott Harris, M.D., Chief Medical Officer

	Date/Time:		Wednesday, June 2, 2021 at 11:30 am ET

A webcast link to the fireside chat presentation will be accessible on the Events section of the Altimmune website.

About Altimmune

Altimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Our diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID™), anthrax (NasoShield™) and influenza (NasoVAX™); an intranasal immune modulating therapeutic for COVID-19 (T-COVID™); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell™). For more information on Altimmune, please visit www.altimmune.com.

Investor & Media Contacts:

Will Brown		Stacey Jurchison
Chief Financial Officer		Sr. Dir, Investor Relations
Phone: 240-654-1450		Phone : 410-474-8200
wbrown@altimmune.com		sjurchison@altimmune.com